NCT04308668: Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2
- State
- Completed
- Phase
- Phase 3
- People
- 1,312 taking part
- Started
- 17 Mar 2020
- Primary completion
- 20 May 2020
- Arms
- Treatment
- Results
- Posted on the registry
- 16 Mar 2020: Trial registered
- 17 Mar 2020: Trial started
- 20 May 2020: Trial completed
- 13 May 2021: Trial results posted